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Abstract
Background: Actigraphy may provide a more valid assessment of sleep, circadian
rhythm (CR), and physical activity (PA) than self‐reported questionnaires, but has not
been used widely to study the association with depression/anxiety and their clinical
characteristics.
Methods: Fourteen‐day actigraphy data of 359 participants with current (n = 93),
remitted (n = 176), or no (n = 90) composite international diagnostic interview
depression/anxiety diagnoses were obtained from the Netherlands Study of
Depression and Anxiety. Objective estimates included sleep duration (SD), sleep
efficiency, relative amplitude (RA) between day‐time and night‐time activity, mid
sleep on free days (MSF), gross motor activity (GMA), and moderate‐to‐vigorous PA
(MVPA). Self‐reported measures included insomnia rating scale, SD, MSF, metabolic
equivalent total, and MVPA.
Results: Compared to controls, individuals with current depression/anxiety had a
significantly different objective, but not self‐reported, PA and CR: lower GMA (23.83
vs. 27.4 milli‐gravity/day, p = .022), lower MVPA (35.32 vs. 47.64min/day, p = .023),
lower RA (0.82 vs. 0.83, p = .033). In contrast, self‐reported, but not objective, sleep
differed between people with current depression/anxiety compared to those without
current disorders; people with current depression/anxiety reported both shorter and
longer SD and more insomnia. More depressive/anxiety symptoms and number of
depressive/anxiety diagnoses were associated with larger disturbances of the
actigraphy measures.
Conclusion: Actigraphy provides ecologically valid information on sleep, CR, and PA
that enhances data from self‐reported questionnaires. As those with more severe or
comorbid forms showed the lowest PA and most CR disruptions, the potential for
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adjunctive behavioral and chronotherapy interventions should be explored, as well as
the potential of actigraphy to monitor treatment response to such interventions.
K E YWORD S
actigraphy, anxiety disorders, circadian rhythm, comorbidity, depressive disorder, dysthymic
disorder, exercise, sleep
1 | INTRODUCTION
Depression and anxiety are highly prevalent psychiatric disorders,
with largely overlapping pathophysiology (Zorn et al., 2017), high
genetic correlation (Wray, 2018), both causing high disability (Vos
et al., 2016) and sharing high degree of comorbidity (Lamers et al.,
2011; Rodney et al., 1997). Sleep and circadian rhythm (CR)
disturbances and altered physical activity (PA) have long been
recognized as core features of depression and anxiety.
Studies have shown that insomnia and hypersomnia are more
frequent among those with a diagnosis of depression (Nutt, Wilson, &
Paterson, 2008; van Mill, Hoogendijk, Vogelzangs, van Dyck, & Penninx,
2010), and comorbid depression and anxiety (van Mill et al., 2010), which
is not surprising as experiencing insomnia or hypersomnia nearly every
day is one of the DSM‐5 diagnostic criteria of depressive disorders. But
more insomnia and hypersomnia have also been reported in anxiety
disorders (Staner, 2003; van Mill et al., 2010). Evening chronotype has
been linked to depressive (Antypa, Vogelzangs, Meesters, Schoevers, &
Penninx, 2016; Norbury, 2019) and anxiety disorders (Kivelä, Papado-
poulos, & Antypa, 2018), depressive symptoms as reported in the meta‐
analysis by Au and Reece (2017) and to comorbid depressive and anxiety
disorders (Antypa et al., 2016). Reduced PA has been reported in patients
with depression as shown in the meta‐analysis by Schuch et al. (2017), in
patients with anxiety (Hiles, Lamers, Milaneschi, & Penninx, 2017;
Ströhle, 2009) and in patients with comorbid depressive and anxiety
disorders (Hiles et al., 2017). These findings are mainly based on
retrospective self‐reported questionnaires, that summarize static esti-
mates, which are potentially biased by patientʼs cognitive impairments
and negative perception (Sallis & Saelens, 2000).
Wrist‐worn actigraphy devices can objectively assess (disturbances
in) sleep, CR, and PA. The ecological measurement with actigraphy in
patients’ natural environments continuously over time may translate
much more readily to potentially effective intervention (Shiffman, Stone,
& Hufford, 2008). For instance, actigraphy may be used for clinical
assessment to monitor treatment outcomes. Although actigraphy has
become widely available in epidemiological research (Doherty et al.,
2017), only few large‐cohort studies have studied the relationship of
sleep, CR, and PA with depression and anxiety in a psychiatric sample
using actigraphy. In addition, there is limited research studying the
association of objective estimates with clinical characteristics, such as
psychiatric comorbidity and chronicity of psychiatric disorders. Thus, a
better understanding on the association of sleep, CR, and PA with
psychopathology that may have important clinical implications, in
particular for the clinical assessment, monitoring, and treatment of
depression and anxiety.
In this study, we investigate whether (a) objective and/or self‐
reported estimates of sleep, CR, and PA differ in persons without and
with remitted or current depressive and/or anxiety disorders; and (b)
objective estimates of PA, sleep, and CR are associated with clinical
characteristics (i.e., severity of symptoms, number of psychiatric
disorders, duration of psychiatric disorders, age of onset, and anti-
depressant use). As part of the objective, (a) we also explore the
correlations between objective and self‐reported estimates of sleep, CR,
and PA. This may give us an insight whether the more objective
actigraphy collection is truly providing novel information.
2 | METHODS
2.1 | Sample
Participants from the Netherlands Study of Depression and Anxiety
(NESDA) were selected to participate in the Ecological Momentary
Assessment (EMA) & Actigraphy sub‐study (NESDA‐EMAA). NESDA is
one of the sites that is a member of the Motor Activity Research
Consortium for Health (m‐MARCH; Scott et al., 2017), a collaborative
network on the application of objective assessment of motor activity,
sleep, and mood in population and clinical samples. Details about NESDA
have been provided extensively before (Penninx et al., 2008). NESDAwas
designed to investigate the course of depressive and anxiety disorders
over a period of several years and the factors that influence the
development and prognosis of such disorders. Participants were initially
included at the baseline assessment in 2004 to 2007 (n =2981), and seen
for the fifth time at the 9‐year follow‐up assessment wave (2014–2017)
for a regular follow‐up interview (n =1776), including a psychiatric
diagnostic interview. Siblings of a subsample of NESDA participants were
(also) included by asking NESDA participants at the regular 9‐year follow‐
up interview for their consent to approach their siblings. Eligibility criteria
were that the NESDA respondent had to meet diagnostic criteria for a
depression or anxiety disorder either in the year before baseline or
during the follow‐up, participated in at least two of the four previous
waves and the current regular interview, and had the same biological
parents as their sibling(s). The NESDA study, including the EMAA
component, was approved by the VUmc ethical committee (reference
number 2003/183) and all respondents gave informed consent for both
the regular interview and the EMAA component.
A flowchart of the NESDA‐EMAA is provided in Figure 1. After the
face‐to‐face 9‐year interview, participants of NESDA who were eligible
and willing to participate in the NESDA‐EMAA sub‐study were invited to
one of our research facilities within 1 month. For this study we invited
NESDA participants who: participated in at least two of the previous
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NESDA waves, consented to be approached for this sub‐study,
participated in the regular interview ≤31 days prior to starting the
EMA measurements, had good mastery of the Dutch language, were
familiar with smartphone use and willing to wear a wrist‐worn actigraphy
device. Siblings were invited if they did not have a current or past
diagnosis of a depressive and/or anxiety disorder or another severe
psychiatric disorder (such as psychotic or severe addiction disorder). All
participants were fully informed and given time to ask questions before
participation. They received an instruction on the EMA and GENEActiv,
and were provided with a GENEActiv device (Activinsights Ltd.,
Kimbolton, UK) as well as a prepaid envelope or box to send the
GENEActiv back by mail after the 2‐week period. Participants wore the
wrist‐worn GENEActiv actigraphy device and took part in the EMA
assessment on a smartphone for 2 weeks during which they filled out
questions on current mood states. If they did not have a smartphone with
internet access, they could borrow one from the study. Of the 384
participants included in the NESDA‐EMAA study, 14 had no available
actigraphy data for several reasons, such as technical failure (see Figure
F IGURE 1 Flow‐chart NESDA‐EMAA study
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1), resulting in 370 (96.4%) participants with available data. According to
previously published criteria (da Silva et al., 2014), participantʼs
actigraphy data were included in the analyses if at least 1 week day
and 1 weekend day of usable data was available, with at least 16 hr
recorded per day and per night (see Supporting Information “Raw data
processing” for further details about the actigraphy data pipeline). The
final sample was composed of 359 (93.5%) participants with 13.68 ±1.26
valid days, of which 90% completed the protocol for 14 days.
2.2 | Diagnosis of depression and/or anxiety
disorders
As in the previous waves, at the 9‐year follow‐up, DSM‐IV–based
diagnoses of depressive disorders (dysthymia and major depressive
disorder) and anxiety (social anxiety disorder, panic disorder with
and without agoraphobia, agoraphobia, and generalized anxiety
disorder) were established with the composite international diag-
nostic interview (CIDI, version 2.1; Wittchen, 1994). The interviews
were conducted by specially trained clinical research staff. For this
study, participants were divided into the following three groups: (a) A
group with no lifetime depressive and/or anxiety disorders, (b) a
group with remitted depressive and/or anxiety disorders (having a
lifetime, but not current [6‐month] diagnosis), and (c) a group with
current depressive or anxiety disorder in the past 6 months.
2.3 | Clinical characteristics
Studied clinical characteristics were the severity of depressive
symptoms and that of anxiety symptoms, number of comorbid
psychiatric disorders, duration of depressive or anxiety disorders, age
of onset, and medication use (i.e., antidepressant and benzodiaze-
pines use). Severity of depressive symptoms and that of anxiety
symptoms were estimated using the 30‐item inventory of depressive
symptomatology (IDS) self‐report (Rush, Gullion, Basco, Jarrett, &
Trivedi, 1996) and the Beck anxiety inventory (BAI; Beck, Epstein,
Brown, & Steer, 1988), respectively. Number of psychiatric disorders
was determined as a count of current depressive and anxiety
diagnoses at the 9‐year follow‐up. Duration of depressive or anxiety
disorder was calculated as a count of the number of waves at which
the patient reported a depression and/or anxiety diagnosis during the
in‐between follow‐up periods (ranging from one to five waves). Age
of onset was derived from the CIDI. Antidepressant use and
benzodiazepine use was based on drug container inspection, and
medications were coded according to the World Health Organization
Anatomical Therapeutic Chemical (ATC) classification. Antidepres-
sant and benzodiazepine use was considered present if participants
reported using it more than 50% of the time. Antidepressants
included were selective serotonin reuptake inhibitors (SSRIs, ATC
code N06AB), tricyclic antidepressant (TCA, ATC code N06AA) and
other antidepressants (ATC codes N06AF, N06AG, N06AX); benzo-
diazepines included ATC codes N03AE, N05BA, N05CD, and N05CF.
2.4 | Actigraphy estimates of sleep, circadian
rhythm, and physical activity
Participants wore the GENEActiv watch on their nondominant wrist
for 2 weeks. They were instructed to wear the watch day and night
and only taking it off when going to the sauna or when playing a
contact sport in which wearing a wristband is unsafe. They were also
instructed to press the button on the device when going to sleep and
when getting up. In this study, the accelerometer was set to sample
at 30 Hz and raw actigraphy data were analyzed using an open
source R package, GGIR (version 1.5–18, see Supporting Information
for further details on the raw actigraphy data cleaning processing
pipeline). Sleep was assessed as total sleep duration per night (in
hh:mm) and sleep efficiency per night (%). CR was assessed by mid
sleep on free days (MSF; clock time) and the relative amplitude (RA)
between day‐time and night‐time activity per day. Physical activity
was assessed as gross motor activity per day (milli‐gravity [mg],
1g = 9.81m/s2) and minutes in moderate‐to‐vigorous PA per day
(objective minutes in moderate‐to‐vigorous PA per day were defined
as the sum of 1‐min epochs in which gross motor activity was larger
than 125mg, which has recently been used by others (Kim et al.,
2017)). Average weekly estimates were derived for each participant.
Actigraphy variables were chosen based on several reasons. First, the
selected actigraphy variables are among the ones reported fre-
quently in adult studies and have been previously linked to
psychopathology (Burton et al., 2013; Hori et al., 2016; Luik et al.,
2015; Lyall et al., 2018). Second, these measures cover the concepts
often collected with self‐reported questionnaires allowing for a
comparison on their association with depressive and anxiety
disorders.
2.5 | Self‐reported sleep, CR, and PA
Self‐reported sleep was evaluated using the following questionnaires:
Insomnia was assessed with the womenʼs health initiative insomnia
rating scale (IRS; Levine et al., 2003), which consists of five questions
on difficulties in falling asleep, disruption and quality of sleep in the
past month with a total score ranging from 0 (no insomnia) to 20
(severe insomnia). Sleep duration was also assessed (i.e., ≤6 hr,
7–9 hr, and ≥10 hr).
Self‐reported chronotype was assessed with the Munich chron-
otype questionnaire (MCTQ; Roenneberg, Wirz‐Justice, & Merrow,
2003). The MCTQ contains 29 questions about time of waking up and
falling asleep on workdays and on free days, at this moment.
Chronotype was defined as the midpoint in time between falling
asleep and waking up on free days (MSF), since it is most likely to be
accurate when oneʼs natural CR can be observed, without the
interference of work schedules and alarm clocks.
Self‐reported PA was assessed with the international PA
questionnaire (IPAQ; Ainsworth et al., 2000). This seven‐item
questionnaire provides information on the respondentʼs time spent
on walking and on vigorous and moderate PA during the last 7 days.
Minutes spent in moderate‐to‐vigorous PA and general PA,
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expressed as metabolic equivalent total (MET, 1 MET
= 1 kcal·kg−1·hr−1) minutes per week were derived from the IPAQ.
MET minutes per week were calculated as level × minutes of
activity × events per week.
The reliability and validity of the used self‐reported question-
naires have been shown before in large‐cohort studies (IRS, Levine
et al., 2003; MCTQ, Zavada, Gordijn, Beersma, Daan, & Roenneberg,
2005; and IPAQ, Craig et al., 2003).
2.6 | Covariates
The covariates were age at the 9‐year follow‐up, sex and education
level expressed in years. These covariates were selected as they have
an established theoretical association with psychopathology and with
sleep, CR, and PA levels, and have been regularly used in similar
studies (Droomers, Schrijvers, & Mackenbach, 2001; Stamatakis,
Kaplan, & Roberts, 2007).
2.7 | Statistical analyses
Distributions of all variables were checked on normality with QQ plots.
For descriptive statistics, participant demographics, clinical character-
istics, actigraphy, and self‐reported estimates of sleep, CR, and PA were
compared between the three groups (i.e., no, remitted, and current
depressive and/or anxiety disorders). For normally distributed continuous
data, analysis of variance (ANOVA) tests were used and for data that
with a non‐normal distribution Kruskall‐Wallis tests were used. χ2 tests
were used to test differences in frequencies in the three groups. We
calculated correlations between actigraphy and self‐reported estimates of
sleep, CR, and PA. Correlations were tested with Pearsonʼs correlation or
with polyserial correlation tests when the variables were continuous or
nominal‐continuous, respectively. This was done for the entire sample as
well as stratified by the main grouping variable.
The association between actigraphy estimates and clinical character-
istics (i.e., severity of depressive symptoms and severity of anxiety
symptoms, number of psychiatric diagnoses, duration of psychiatric
diagnoses, age of onset, and antidepressant use) was tested in separate
models using linear regression model corrected for covariates and with
each actigraphy estimate as outcome. Analyses to study the association
with number of psychiatric diagnoses, duration of psychiatric diagnoses,
age of onset, and antidepressant use were performed only including
participants with current depressive and/or anxiety disorders. Non‐
normally distributed outcomes were transformed with log‐transformation
or with Box‐Cox transformation.
All analyses were performed with the statistical software R
(version 1.0.143), a p < .05 was considered statistically significant.
Posthoc tests were performed to allow multiple comparison for
actigraphy estimates with Dunnʼs test when the differences between
the three groups, that is, no, remitted, and current depressive
and/or anxiety disorders were significant. To get a more compre-
hensive picture, we also performed posthoc analyses to check
whether day‐to‐day variability in actigraphy estimates (calculated







n 93 176 90 p
Demographics
Age, mean (SD)a 50.1 (11.1) 48.2 (13.4) 51.3 (12.5) .13
Female, n (%)b 58 (62.4) 120 (68.2) 50 (55.6) .12
Education level (years), mean (SD) 12.5 (3.4) 12.7 (2.8) 13.9 (2.9) <.001
Psychopathology
Only depressive disorders, n (%) 26 (28.7) 46 (26.1) ‐
Only anxiety disorders, n (%) 36 (38.3) 24 (13.6) ‐
Depressive & anxiety disorders, n (%) 31 (33.0) 106 (60.2) ‐
Number of psychiatric disorders, median
(IQR)
1 (1) ‐ ‐
Duration of psychiatric disorder/s (number
of waves), median (IQR)
5 (1) 2 (2) ‐
Age of depressive disorder or anxiety onset,
mean (SD)
17.2 (12.2) 21.7 (12.9) ‐
Psychological scales
Inventory of depressive symptomatology
(IDS), mean (SD)a
24.9 (13.2) 13.1 (8.9) 5.4 (3.8) <.001
Beck anxiety inventory (BAI), mean (SD)a 13.6 (10.5) 6.1 (5.7) 1.6 (1.9) <.001
Medication use
Antidepressant users, n (%)b 35 (37.2) 34 (19.3) 2 (2.2) <.001
Benzodiazepines users, n (%)b 5 (5.3) 8 (4.5) 0 (0.0) .10
Abbreviations: IQR, interquartile range; SD, standard deviation
Bold value indicate p < .05.
aAnalysis of variance (ANOVA)
bχ2 test
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as the SD across 14 days) was associated with depressive and/or
anxiety disorders.
The potential clustering of NESDA participants with their siblings
was ignored, as of the 27 siblings included in the analyses, only seven
were linked to NESDA participants in this sample. Analyses were
rerun without the siblings that were linked to NESDA participants,
but this did not alter results (data not shown).
3 | RESULTS
The sample demographics and clinical characteristics are described in
Table 1. Of the total sample (n = 359), 93 had current and 176 had
remitted depressive and/or anxiety disorders, 90 had no current
depressive and/or anxiety disorders. The current depressive/anxiety
disorder group was heterogeneous: In that, 38.3% had anxiety
disorders only, 33.0% had depressive and anxiety disorders, and
28.7% had depressive disorders only. As expected, persons with
current depressive and/or anxiety disorders scored significantly
higher on depressive and anxiety symptoms (both p < .001) and more
frequently used antidepressant than both other groups, but no
significant differences were found for benzodiazepine use.
When using actigraphy, persons with current depressive and/or
anxiety disorders were significantly less active and had significantly
lower RA between day‐time and night‐time activity compared to
controls (p < .05, Table 2). We did not find significant differences for
objective sleep duration and sleep efficiency. Self‐reported sleep, but
not self‐reported PA or CR measures, differed significantly across
groups (p < .001, Table 2). Low to moderate correlations were
observed between self‐reported and objective estimates of sleep,
CR, and PA (Table 3); objective and self‐reported sleep estimates
were not significantly correlated, low but statistically significant,
correlations were found between objective and self‐reported PA
estimates, and moderate and significant correlations between
objective and self‐reported CR estimates were observed. When
stratifying by diagnostic status (i.e., no, remitted, and current
depressive and/or anxiety disorders), we observed that correlations
for mid sleep on free days were higher in the control group compared








Sleep duration (clock time), mean (SD)b 6:59 (1:08) 7:02 (0:59) 6:53 (0:58) .478
Sleep durationc .333
<7 hr, % 33.3 27.8 25.6
7 ≤ hr ≤ 9, % 64.5 71.6 74.4
>9 hr, % 2.2 0.6 0.0
Sleep efficiency (%), median (IQR)a 87.0 (8.0) 88.0 (7.0) 88.0 (6.0) .170
Self‐reported sleep durationc <.001de
≤6 hr, % 40.9 19.9 13.3
7 ≤ hr ≤ 9, % 53.8 76.7 86.7
≥10 hr, % 5.4 3.4 0.0
Insomnia rating scale, mean (SD)b 8.95 (4.74) 6.87 (4.46) 5.4 (3.52) <.001de
Circadian rhythm
Relative amplitude between day‐time and
night‐time activity level, median (IQR)a
0.81 (0.08) 0.83 (0.06) 0.83 (0.06) .028d
Mid sleep on free days (clock time), median
(IQR)a
04:10 (01:31) 04:11 (01:17) 04:14 (01:07) .883
Self‐reported Mid Sleep on Free Days
(clock time), mean (SD)b
04:03 (01:10) 03:55 (01:06) 04:00 (00:52) .628
Physical activity
Gross motor activity (milli‐gravity), median
(IQR)a
23.80 (9.88) 26.90 (9.47) 27.40 (10.30) .021d
Moderate‐to‐vigorous physical activity
(min/day), median (IQR)a
35.14 (35.43) 45.21 (44.32) 47.39 (41.91) .029d
Self‐reported moderate‐to‐vigorous
physical activity (min/day), median (IQR)a
90 (139) 115 (120) 120 (120) .061
Total MET‐min/week/1,000, median (IQR)a 2.19 (3.39) 2.85 (4.28) 2.60 (2.99) .067
Abbreviations: IQR, interquartile range; MET, metabolic equivalent total; SD, standard deviation
Bold value indicate p < .05.
aKruskal‐Wallis test.
bAnalysis of variance (ANOVA).
cχ2 test.
dDunnʼs test, current depressive and/or anxiety disorders versus no depressive and/or anxiety disorders, p < .05.
eDunnʼs test, current depressive and/or anxiety disorders versus remitted depressive and/or anxiety disorders, p < .05.
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to patients with remitted and current depressive and/or anxiety
disorders (Supporting Information, Table S1). On the other hand,
correlations for PA estimates were no longer significant in people
without depressive and/or anxiety disorders compared to the other
groups (Supporting Information, Table S1). Our posthoc analyses on
day‐to‐day variability in actigraphy estimates showed that patients
with current depressive and/or anxiety disorders had significantly
lower day‐to‐day variability in moderate‐to‐vigorous PA compared to
controls (Supporting Information, Table S2).
Having higher levels of depressive and anxiety symptoms was
significantly associated with longer sleep duration, lower RA between
day‐time and night‐time activity level, reduced gross motor activity,
and moderate‐to‐vigorous PA (Table 4). Looking at the smaller sized
group of 93 persons with current depressive and/or anxiety disorders,
number of psychiatric diagnoses was the only clinical characteristic
significantly associated with longer sleep duration, lower RA between
day‐time and night‐time activity level, lower gross motor activity, and
moderate‐to‐vigorous PA Table 4). Antidepressant use was signifi-
cantly associated with delayed mid sleep on free days (Table 4).
4 | DISCUSSION
In this study, we found reduced PA level and daily rhythm
disturbances among those with depressive and anxiety disorders
compared to controls using objective measures, but not using self‐
reported information. By contrast, self‐reported but not objective
sleep measures differed between persons with depressive and anxiety
disorders versus controls. Actigraphy estimates gathered in an
ecologically valid manner during continuous registration over
2‐week time revealed objective differences in PA and CR measures
between diagnostic groups that were not captured with self‐reported
questionnaires. Moreover, self‐reported sleep appeared to reflect the
sleep misperception commonly presented in persons with depressive
and anxiety symptoms (Dittoni et al., 2013). This supports the use of
actigraphy in the assessment of PA, sleep, and CR disturbances in
epidemiological studies and clinical practice enhancing subjective data
from the traditional self‐reported questionnaires. The high participa-
tion response to the study confirms the feasibility and acceptability of
monitoring patients with depressive and anxiety disorders with
actigraphy, which may translate to the clinical setting as well.
We found lower levels of objective PA (and lower day‐to‐day
variability in objective PA) in persons with a current diagnosis, versus
those with remitted or no diagnosis. Posthoc analysis (data not
shown) confirmed that associations for pure anxiety and pure
depression cases were similar. Patients with current depression
and anxiety spent on average 35min per day in moderate‐to‐
vigorous PA and a similar effect size has been found in the meta‐
analysis on depression by Schuch et al. (2017). In terms of the
association between CR disturbances with psychopathology, we
found that depressive and anxiety disorders are associated with
lower RA between day‐time and night‐time activity levels. Similarly,
previous studies have shown that CR appears to be dampened in
patients with depression (Hori et al., 2016) and mood disorders (Lyall
et al., 2018; Shou et al., 2017), suggesting that the lower level of daily
activity is a core feature of mood disorders (Burton et al., 2013).
Importantly, less research has been conducted for anxiety, however,
our results showed similar effects to those in depression. Reduced
daily activity level and CR amplitude may be indicative of
psychomotor retardation, withdrawal from normal activities of daily




(MCTQ) Physical activity (IPAQ)
Actigraphy estimates IRSa Sleep durationb Mid Sleep on Free Daysa METa MVPAa
Sleep
Sleep duration 0.076 0.019 −0.017 −0.008 0.005
Sleep efficiency −0.082 −0.043 −0.087 0.031 0.009
Circadian rhythm
Relative amplitude between day‐time and night‐time
activity level
−0.179*** 0.231*** −0.140** 0.235*** 0.146**
Mid sleep on free days −0.078 0.075 0.582*** −0.025 −0.017
Physical activity
Gross motor activity −0.113* 0.105 −0.028 0.286*** 0.203***
MVPA −0.089 0.134 0.009 0.258*** 0.177***
Abbreviations: IPAQ, international physical activity questionnaire; IRS, womenʼs health initiative insomnia rating scale; MCTQ, Munich chronotype
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living (Burton et al., 2013) and circadian impairments (Lyall et al.,
2018). As improvement in depression with antidepressant medica-
tions have been linked with greater day‐time activity levels (Todder,
Caliskan, & Baune, 2009) and higher RA between day‐time and night‐
time activity (Todder et al., 2009) when using actigraphy, the
continuous measurement of daily activity and circadian rhythmicity
with wrist‐worn actigraphy may help to monitor treatment effects
(Martin & Hakim, 2011).
However, first some conditions should be met before actigraphy
could play a role in monitoring of treatment response. Although it has
been suggested that actigraphy could be used to follow the
progression of depression treatment, it is still unclear how sensitive
and specific actigraphy is for the characterization of this change in
psychological state (Martin & Hakim, 2011). Which actigraphy
variables are best suited for monitoring purposes and definitions of
clinically relevant improvement on these variables needs to be
examined. Interpretation is also not always immediate (e.g., RA
between day‐time and night time activity) and clinicians may need
additional training for the use of devices in the clinical practice.
Wearing research devices such as a GENEActiv device, may be
experienced as stigmatizing as a patient may be asked for its use in
public (Scott et al., 2019; Simblett et al., 2019). Popular commercial
activity trackers are aesthetically pleasing and therefore maybe less
stigmatizing, but at a cost of lower quality data—whether these
devices are suitable for monitoring treatment effects is unknown
(Scott et al., 2019). Currently, the majority of devices used in
research settings need to be connected to a computer to download
data and to extract variables with the use of specific software,
resulting in a time‐consuming procedure. In the future, devices with
bluetooth‐compatible connectivity and consumer devices are likely to
become more common, allowing the real‐time synchronization of
data on the patientʼs smartphone app and on a data visualization
dashboard. Data may become readily available and interpretable for
the clinician, while for the patient, real‐time feedback on activity and
sleep may help to adopt more healthy habits (Matcham et al., 2019).
While actigraphy appeared to enhance information obtained from
self‐reported questionnaires, self‐reported assessment can also be
improved by using a daily electronic diary that is less costly and time
consuming than actigraphy and it may be more personalized to
individuals (Martin & Hakim, 2011). Such electronic diaries may
also incorporate other questionnaires on sleep and sleep quality
such as the Pittsburgh sleep quality index or the insomnia
severity index.
Actigraphy indices of sleep were not significantly different across
diagnostic groups. Moreover, while sleep duration measured with
actigraphy was not associated with depression and anxiety, self‐
reported sleep duration was consistently associated with psycho-
pathology in the current study and elsewhere (Luik et al., 2015). Self‐
reported and objectively assessed sleep duration also appeared to be
poorly correlated, and this possibly indicates that perceived sleep
reflects different aspects of sleep than the objective estimate. This
might be due to sleep misperception, which is more common in
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2013), and is influenced by their negative perception. It has been
argued (Harvey & Tang, 2013) that this tendency to misperceive sleep
does not preclude the presence of a real sleep deficit. Perhaps, the
increased worry associated with insomnia makes it more difficult for
patients to move into the deeper stages of sleep and the lighter stages
of sleep may be more likely to be perceived as wake (Harvey & Tang,
2013). It should be also mentioned that the tendency to misperceive
sleep may be considered as a “prodromic or transitional state” in the
development of insomnia that is characterized by a serious objective
sleep deficit (Harvey & Tang, 2013). Thus, actigraphy may be used to
determine whether self‐reported sleep problems are not consistent
with objective sleep, and the patient would potentially benefit from
psychologic treatments to reverse misperception, such as cognitive
behavioral therapy (Martin & Hakim, 2011).
We also found evidence for dose‐response associations as those
with more severe depressive and anxiety symptoms were signifi-
cantly less active and showed longer sleep duration and lower RA
between day and night activity level. Furthermore, in the group with
current depression and/or anxiety, we found that psychiatric
comorbidity was associated with physical inactivity, longer sleep
duration, and lower RA between day and night activity level. As PA
and CR are modifiable factors, exercise, behavioral activation, and
chronotherapy may be offered as adjunctive treatments to usual care
in these groups of patients (Carek, Laibstain, & Carek, 2011; Chum
et al., 2017; Morgenthaler et al., 2007). The dose‐response relation-
ships provide further evidence for the ecological validity of
actigraphy. Although, recent clinical trials have employed actigraphy
to monitor activation therapy (Averill et al., 2019) and sleep
deprivation (Arnedt et al., 2017) as adjunctive treatments to usual
care, or as a tool to complement behavioral activation (Chum et al.,
2017), more research is needed to clarify whether actigraphy may be
used to monitor treatment outcomes of such interventions.
Sleep duration was found to be longer in persons with a greater
number of depressive and anxiety symptoms. This can be explained
by the fact that hypersomnia is one of the symptoms of depression
and it usually characterizes patients with atypical features. Another
explanation may be antidepressant use. More severe cases are more
likely to use these medications, and, previous research has suggested
that long sleep duration can be a result of antidepressant use
(Robillard et al., 2015), such as sedating tricyclic antidepressants
(Wichniak & Jernajczyk, 2017). While benzodiazepine use could also
be an explanation, as it is also prescribed for sleep problems, it is a
less likely explanation here, as only five cases used benzodiazepines,
and analyses excluding these cases did not alter findings (data not
shown). Another possible explanation of our findings is that the used
sleep detection algorithm may misclassify period of inactivity as sleep
period, which may be possible since patients with depression and
anxiety exhibit more sedentary behavior.
Shifted and delayed rhythm have been previously documented in
patients with depression (Hori et al., 2016) and anxiety (Robillard et al.,
2015) supporting the evidence for an association between late
chronotypes and psychopathology. In our sample, we noticed later mid
sleep on free days among current cases using antidepressant medication
after covariate adjustments. As antidepressant use may result in more
day‐time sleepiness and fatigue (Fava, 2003) and longer sleep duration
(Robillard et al., 2015), this may possibly explain this finding.
Some limitations should be considered in the current study.
Although actigraphy provides an estimate of sleep parameters such
as sleep duration, sleep efficiency, it does not yield estimates of sleep
stage, such as REM period that may be associated with depression. In
addition, it was not possible to extrapolate actigraphy sleep
estimates indicative of insomnia such as sleep‐onset latency (i.e.,
time to transit from full wakefulness to sleep) and wake after sleep
onset (i.e., periods of wakefulness occurring after sleep onset).
Studies have also shown that actigraphy lacks the precision of the
gold standard polysomnography that provides greater insight into
sleep problems in people with depression or anxiety (Van Hees et al.,
2015). Because sleep is inferred from a lack of movement, there may
be some misclassification of sleep among those who are awake but
motionless. Therefore, the technique is biased toward overestimating
total sleep duration, which may lead to incorrectly minimizing the
severity of sleep disturbances. Likewise, assessment of CR with
actigraphy may not reflect the underlying circadian biology and may
be influenced by unmeasured demographics and other lifestyle
factors (Luik, Zuurbier, Hofman, Van Someren, & Tiemeier, 2013). We
also based our threshold for MVPA on that of other studies (Kim
et al., 2017), but there is no consensus on these thresholds. We also
used a less frequently reported measure of chronotype (sleep
midpoint on free days). Chronotype is often represented as sleep
midpoint on free days corrected for sleep‐debt accumulated during
working days (MSFsc; Roenneberg et al., 2003). As we did not find
associations with MSF and MSF and MSFsc were previously found to
be highly correlated in the NESDA sample (r = 0.91; Antypa et al.,
2016), we did not expect to find different results in our analysis and
the conclusions would not change. Nevertheless, the overall
chronotype (early, intermediate, and late chronotype) across a
sample may influence any correlational associations leading to
inconsistent associations with psychopathology (Dimitrov et al.,
2018). It should also be noted that the self‐reported questionnaires
and the actigraphy measurement did not capture the same time
period; questionnaires were filled out before actigraphy. We also
used a limited number of sociodemographic covariates in this study
(i.e., age, sex, education). Future analyses may take other variables
into account (e.g., BMI, employment status) to study what factors
may explain the association of sleep, CR, and PA with psychopathol-
ogy. Correction for multiple testing was also not performed and may
have led to finding statistical associations for chance. Strengths of
the study are the inclusion of both depressive and anxiety disorder,
and the ability to look in‐depth at the role of clinical characteristics.
While the measures presented in this paper provide some
preliminary insight into the objectively measured PA, sleep, and
CRs and the differences therein between diagnostic groups, these
measures are summaries of a much richer underlying data set. Using
studies from our collaborative Motor Activity Research Consortium
for Health (m‐MARCH) initiative (www.mmarch.org, Scott et al.,
2017), we plan to employ more sophisticated analytical tools have
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been developed that can improve our understanding of these
features, such as functional principal component analyses (Gershon,
Ram, Johnson, Harvey, & Zeitzer, 2016), and functional scalar
regression (Goldsmith, Zipunnikov, & Schrack, 2015). These ap-
proaches will enhance the power and gain greater insight into these
patterns and their relationship to depression and anxiety disorders.
To conclude, we found that persons with current depression and/
or anxiety exhibit reduced PA and more CR disturbances than
controls using actigraphy. As the correlations of actigraphy estimates
with self‐report measures were generally low, actigraphy monitoring
was shown to provide an easy and noninvasive approach to capture
objective information regarding both night time sleep and day‐time
activity, and, sleep and CR. In addition, persons with greater severity
and, among current cases, with more psychiatric comorbidity showed
lower PA and more CR disturbances. Therefore, adjunctive behavior-
al and chronotherapy interventions in depression and anxiety may
especially focus on these individuals. While this study confirms the
feasibility and acceptability of monitoring patients, more research is
needed to establish whether actigraphy could, possibly, in the future,
play a role in monitoring treatment response to such interventions.
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